Mark Talamonti to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Mark Talamonti has written about Carcinoma, Hepatocellular.
Connection Strength
0.357
-
Clinical features of primary and metastatic hepatic malignancies. Cancer Treat Res. 2001; 109:1-14.
Score: 0.137
-
Liver transplant offers a survival benefit over margin negative resection in patients with small unifocal hepatocellular carcinoma and preserved liver function. Surgery. 2018 03; 163(3):582-586.
Score: 0.111
-
Orthotopic liver transplantation provides a survival advantage compared with resection in patients with hepatocellular carcinoma and preserved liver function. Surgery. 2017 11; 162(5):1032-1039.
Score: 0.108